Florida SB 868: Social Media Use by Minors

Bill Text

868 
Practice of the Profession of Pharmacy 
2025-12-10T09:55:11Z 
Authorizing pharmacists who meet specified criteria to, at the direction of a licensed physician, administer medications at a Level I or Level II trauma center under certain circumstances; requiring trauma centers to retain certain documentation to employ pharmacists to perform such tasks, etc. 
Original Filed Version 
2026 
S 
2026-07-01T00:00:00Z 
GB 
General Bill 
__ 

 Florida Senate - 2026 SB 868 

 By Senator Sharief 

 35-01084-26 2026868__ 
 1 A bill to be entitled 
 2 An act relating to practice of the profession of 
 3 pharmacy; amending s. 465.003, F.S.; revising the 
 4 definition of the term “practice of the profession of 
 5 pharmacy”; creating s. 465.1894, F.S.; authorizing 
 6 pharmacists who meet specified criteria to, at the 
 7 direction of a licensed physician, administer 
 8 medications at a Level I or Level II trauma center 
 9 under certain circumstances; requiring trauma centers 
 10 to retain certain documentation to employ pharmacists 
 11 to perform such tasks; requiring the Board of Pharmacy 
 12 to adopt rules; reenacting ss. 465.1901 and 
 13 626.8825(1)(r), F.S., relating to the practice of 
 14 orthotics and pedorthics and pharmacy benefit manager 
 15 transparency and accountability, respectively, to 
 16 incorporate the amendment made by this act to s. 
 17 465.003, F.S., in references thereto; providing an 
 18 effective date. 
 19 
 20 Be It Enacted by the Legislature of the State of Florida: 
 21 
 22 Section 1. Subsection (22) of section 465.003, Florida 
 23 Statutes, is amended to read: 
 24 465.003 Definitions.—As used in this chapter, the term: 
 25 (22) “Practice of the profession of pharmacy” includes 
 26 compounding, dispensing, and consulting concerning contents, 
 27 therapeutic values, and uses of any medicinal drug; consulting 
 28 concerning therapeutic values and interactions of patent or 
 29 proprietary preparations, whether pursuant to prescriptions or 
 30 in the absence and entirely independent of such prescriptions or 
 31 orders; and conducting other pharmaceutical services. For 
 32 purposes of this subsection, the term “other pharmaceutical 
 33 services” means monitoring the patient’s drug therapy and 
 34 assisting the patient in the management of his or her drug 
 35 therapy, and includes reviewing, and making recommendations 
 36 regarding, the patient’s drug therapy and health care status in 
 37 communication with the patient’s prescribing health care 
 38 provider as licensed under chapter 458, chapter 459, chapter 
 39 461, or chapter 466, or a similar statutory provision in another 
 40 jurisdiction, or such provider’s agent or such other persons as 
 41 specifically authorized by the patient; and initiating, 
 42 modifying, or discontinuing drug therapy for a chronic health 
 43 condition under a collaborative pharmacy practice agreement. 
 44 This subsection may not be interpreted to permit an alteration 
 45 of a prescriber’s directions, the diagnosis or treatment of any 
 46 disease, the initiation of any drug therapy, the practice of 
 47 medicine, or the practice of osteopathic medicine, unless 
 48 otherwise permitted by law or specifically authorized by s. 
 49 465.1865 or s. 465.1895. The term “practice of the profession of 
 50 pharmacy” also includes any other act, service, operation, 
 51 research, or transaction incidental to, or forming a part of, 
 52 any of the foregoing acts, requiring, involving, or employing 
 53 the science or art of any branch of the pharmaceutical 
 54 profession, study, or training, and shall expressly permit a 
 55 pharmacist to transmit information from persons authorized to 
 56 prescribe medicinal drugs to their patients. The practice of the 
 57 profession of pharmacy also includes the administration of 
 58 vaccines to adults pursuant to s. 465.189; the testing or 
 59 screening for and treatment of minor, nonchronic health 
 60 conditions pursuant to s. 465.1895; and the preparation of 
 61 prepackaged drug products in facilities holding Class III 
 62 institutional pharmacy permits. The term also includes the 
 63 ordering and evaluating of any laboratory or clinical testing; 
 64 conducting patient assessments; and modifying, discontinuing, or 
 65 administering medicinal drugs pursuant to s. 465.0125 by a 
 66 consultant pharmacist. The term also includes the ordering and 
 67 administration of the federal Clinical Laboratory Improvement 
 68 Amendments-waived tests, including serology tests authorized by 
 69 the United States Food and Drug Administration (FDA) or an 
 70 equivalent regulatory authorization, subject to the disclaimers 
 71 and limitations required by the FDA for such tests. 
 72 Section 2. Section 465.1894, Florida Statutes, is created 
 73 to read: 
 74 465.1894 Administration of medications.— 
 75 (1) A pharmacist, at the direction of a physician licensed 
 76 under chapter 458 or chapter 459, who meets